Abstract:Local response prediction for brain metastases (BMs) from lung cancer after Whole-Brain Radiotherapy (WBRT) is challenging, as existing criteria are based solely on unidimensional measurements. This study sought to determine whether radiomic features of lung cancer BMs derived from pre-treatment magnetic resonance imaging (MRI) could be used to predict local response following WBRT.A total of 88 Lung Cancer patients with BMs treated with WBRT were analyzed. After volumes of interest were drawn, 944 radiomic features including first-order, shape, Gray Level Co-occurrence Matrix (GLCM), Gray Level Dependence Matrix (GLDM), Gray Level Run Length Matrix (GLRLM), Gray Level Size Zone Matrix (GLSZM), Neighborhood Gray Tone Difference Matrix (NGTDM), and Laplacian of Gaussian (LoG) features were extracted, using the baseline pre-treatment post-contrast T1 (T1c) and T2 fluid-attenuated inversion recovery (FLAIR) MRI sequences, respectively. Local response status was determined by contrasting the baseline and follow-up MRI according to the RANO-BM criteria. The independent samples t test or Mann-Whitney U test, and then least absolute shrinkage and selection operator (LASSO) were used for dimensionality reduction and feature selection. An adaboost classifier was trained using the selected radiomic features and evaluated using the area under the receiver operating characteristic curve (AUC) in both the training and testing sets. Other discrimination metrics, including classification accuracy, positive predictive value (PPV), negative predictive value (NPV), sensitivity, and specificity, were also calculated.The optimal radiomics signature was developed based on a multivariable logistic regression with 4, 5, 6 radiomic features on T1c, T2 FLAIR and T1c+T2 FLAIR, respectively. The radiomics model based on T1c features presented the AUC of (0.920 vs. 0.805, respectively) for both the training and testing sets, followed by T2 FLAIR features (0.893 vs. 0.701, respectively), and T1c+T2 FLAIR features (0.971 vs. 0.857, respectively). The classification accuracy of the radiomics model also well predicted the local response of BMs for both the models), and training and testing sets (T1c: 82.9% vs. 77.8%, T2 FLAIR: 82.9% vs. 77.8%, T1c+T2 FLAIR: 90.0% vs. 77.8%, respectively).Radiomics holds promise for predicting local tumor response following WBRT in patients with lung cancer and brain metastases. A predictive model built on radiomic features from an institutional cohort performed well on cross-validation testing. These results warrant further validation in independent datasets. Such work could prove invaluable for guiding management of individual patients and assessing outcomes of novel interventions.

CT-Based Radiomics Model for Predicting Brain Metastasis in Category T1 Lung Adenocarcinoma

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With ALK-Rearranged Non-Small Cell Lung Cancer

“Application of CT Radiomics in Brain Metastasis of Lung Cancer: A Systematic Review and Meta-Analysis”

Thoracic CT Radiomics Analysis for Predicting Synchronous Brain Metastasis in Patients with Lung Cancer

CT-based Radiomics for Predicting Brain Metastases As the First Failure in Patients with Curatively Resected Locally Advanced Non-Small Cell Lung Cancer.

Potential of radiomics analysis and machine learning for predicting brain metastasis in newly diagnosed lung cancer patients

Radiomics Based on Brain-to-tumor Interface Enables Prediction of Metastatic Tumor Type of Brain Metastasis: a Proof-of-concept Study

A Radiomics Model Developed from Pre-Metastatic Brain Magnetic Resonance Imaging to Predict Brain Metastasis in Non–small-Cell Lung Cancer: Evidence to the Seed-and-soil Theory.

A “Seed-and-soil” Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation

Establishing a predictive model for tumor mutation burden status based on CT radiomics and clinical features of non-small cell lung cancer patients

CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma

Clinical-Radiomics Model Enhancing Prediction of Occult Nodal Metastasis in Ct1a-Bn0m0-stage Lung Adenocarcinoma: A Multi-center Study

Distinguishing Multiple Primary Lung Cancers from Intrapulmonary Metastasis Using CT-based Radiomics

MRI-Based Radiomics Signature for the Prediction of Response of Lung Cancer Brain Metastases after Whole-Brain Radio-Therapy

Application of Radiomics Signature Captured from Pretreatment CT to Predict Brain Metastases in Stage III/IV Non-small Cell Lung Cancer Patients with ALK Mutation

PredictionriskofbrainmetastasesinEGFRpositivenon-smallcelllungcancer patients based on thoracic CT radiomics

Development and Validation of a CT-Based Signature for the Prediction of Distant Metastasis Before Treatment of Non-Small Cell Lung Cancer.

Application of Radiomics Signature Captured from Pretreatment Thoracic CT to Predict Brain Metastases in Stage III/IV ALK-positive Non-Small Cell Lung Cancer Patients

Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature

A CT‐based Radiomics Model to Predict Subsequent Brain Metastasis in Patients with ALK‐rearranged Non–small Cell Lung Cancer Undergoing Crizotinib Treatment